Lenalidomide: deciphering mechanisms of action in myeloma, myelodysplastic syndrome and beyond

scientific article

Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 159 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 159 Warning: foreach() argument must be of type array|object, null given in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 161
Lenalidomide: deciphering mechanisms of action in myeloma, myelodysplastic syndrome and beyond is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CEB.2015.10.004
P8608Fatcat IDrelease_wrvkk2uekzcq7fy7fgdsgm7wi4
P698PubMed publication ID26512454

P50authorAndrew A GuirguisQ61090111
P2093author name stringBenjamin L Ebert
P921main subjectmyelodysplastic syndromeQ954625
P304page(s)61-67
P577publication date2015-10-26
P1433published inCurrent Opinion in Cell BiologyQ13505682
P1476titleLenalidomide: deciphering mechanisms of action in myeloma, myelodysplastic syndrome and beyond
P478volume37

Reverse relations

cites work (P2860)
Q38649220Biological evaluation of both enantiomers of fluoro-thalidomide using human myeloma cell line H929 and others.
Q33433453Clinical Pharmacokinetics and Pharmacodynamics of Lenalidomide
Q58299695IMiD compounds affect CD34 cell fate and maturation via CRBN-induced IKZF1 degradation
Q39166988Immune defects caused by mutations in the ubiquitin system
Q48226736Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy.
Q57035464PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs
Q50853038Specific targeting of the deubiquitinase and E3 ligase families with engineered ubiquitin variants
Q92955229Targeting chromatin complexes in fusion protein-driven malignancies
Q41619260Thalidomide and lenalidomide for recurrent ovarian cancer: A systematic review of the literature
Q42101565pSILAC mass spectrometry reveals ZFP91 as IMiD-dependent substrate of the CRL4CRBN ubiquitin ligase

Search more.